Chemerin in immune response and gastrointestinal pathophysiology.

[1]  Amir Abbasnezhad,et al.  Serum Levels of Chemerin, Apelin, and Adiponectin in Relation to Clinical Symptoms, Quality of Life, and Psychological Factors in Irritable Bowel Syndrome , 2020, Journal of clinical gastroenterology.

[2]  Jie Xu,et al.  Association of serum chemerin and inflammatory factors with type 2 diabetes macroangiopathy and waist-to-stature ratio. , 2019, Bosnian journal of basic medical sciences.

[3]  K. Goralski,et al.  More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer , 2019, International journal of molecular sciences.

[4]  Ulfat M. Omar,et al.  Insulin resistance and its correlation with chemerin and visfatin in Saudi patients with hyperthyroidism , 2019, International journal of health sciences.

[5]  Rui-Li Zhang,et al.  Chemerin induced by Treponema pallidum predicted membrane protein Tp0965 mediates the activation of endothelial cell via MAPK signaling pathway , 2019, Journal of cellular biochemistry.

[6]  Y. Ueno,et al.  Association between High Levels of Circulating Chemerin and Colorectal Adenoma in Men , 2019, Digestion.

[7]  H. Völzke,et al.  Associations of circulating chemerin and adiponectin concentrations with hepatic steatosis , 2019, Endocrine connections.

[8]  Yanjun Dan,et al.  Chemerin partly mediates tumor‐inhibitory effect of all‐trans retinoic acid via CMKLR1‐dependent natural killer cell recruitment , 2019, Immunology.

[9]  E. Butcher,et al.  Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment , 2019, Front. Immunol..

[10]  A. Prystupa,et al.  Factors influencing serum chemerin and kallistatin concentrations in patients with alcohol-induced liver cirrhosis. , 2019, Annals of agricultural and environmental medicine : AAEM.

[11]  L. Hsu,et al.  Circulating Chemerin Levels, but not the RARRES2 Polymorphisms, Predict the Long-Term Outcome of Angiographically Confirmed Coronary Artery Disease , 2019, International journal of molecular sciences.

[12]  M. Schulze,et al.  Association of Chemerin Plasma Concentration With Risk of Colorectal Cancer , 2019, JAMA network open.

[13]  R. Beynon,et al.  Chemerin acts via CMKLR1 and GPR1 to stimulate migration and invasion of gastric cancer cells: putative role of decreased TIMP-1 and TIMP-2 , 2019, Oncotarget.

[14]  Hongshan Chen,et al.  Serum Chemerin Levels Correlate With Determinants of Metabolic Syndrome in Obese Children and Adolescents , 2019, Clinical medicine insights. Pediatrics.

[15]  B. Zabel,et al.  Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention , 2018, Front. Immunol..

[16]  A. Papavassiliou,et al.  Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer. , 2018, Lung cancer.

[17]  M. Gayyed,et al.  Expression of chemerin correlates with a poor prognosis in female breast cancer patients , 2018, Breast cancer.

[18]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[19]  H. Ju,et al.  Circulating chemerin levels and gestational diabetes mellitus: a systematic review and meta-analysis , 2018, Lipids in Health and Disease.

[20]  T. Reinehr,et al.  Link between chemerin, central obesity, and parameters of the Metabolic Syndrome: findings from a longitudinal study in obese children participating in a lifestyle intervention , 2018, International Journal of Obesity.

[21]  M. Alkady,et al.  Assessment of Serum Levels of the Adipocytokine Chemerin in Colorectal Cancer Patients , 2018, Journal of medical biochemistry.

[22]  P. Shi,et al.  The involvement of iron in chemerin induced cell cycle arrest in human hepatic carcinoma SMMC7721 cells. , 2018, Metallomics : integrated biometal science.

[23]  P. Horn,et al.  Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis , 2018, Scientific Reports.

[24]  G. Fink,et al.  The chemerin knockout rat reveals chemerin dependence in female, but not male, experimental hypertension , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  Liangan Hu,et al.  Relationship of circulating chemerin and omentin levels with Th17 and Th9 cell immune responses in patients with asthma , 2018, The Journal of asthma : official journal of the Association for the Care of Asthma.

[26]  D. Xie,et al.  Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis , 2018, British Journal of Cancer.

[27]  H. Randeva,et al.  Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesion , 2018, Oncotarget.

[28]  L. Hsu,et al.  Pleiotropic Associations of RARRES2 Gene Variants and Circulating Chemerin Levels: Potential Roles of Chemerin Involved in the Metabolic and Inflammation-Related Diseases , 2018, Mediators of inflammation.

[29]  D. Greaves,et al.  Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses In Vivo , 2017, Front. Immunol..

[30]  J. Qian,et al.  Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia , 2017, Oncotarget.

[31]  M. Kukla,et al.  Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease. , 2017, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[32]  C. Buechler,et al.  Chemokine (CC-motif) receptor-like 2 mRNA is expressed in hepatic stellate cells and is positively associated with characteristics of non-alcoholic steatohepatitis in mice and men. , 2017, Experimental and molecular pathology.

[33]  J. Jeon,et al.  Serum chemerin levels are independently associated with quality of life in colorectal cancer survivors: A pilot study , 2017, PloS one.

[34]  B. Li,et al.  Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation , 2017, Oncogene.

[35]  C. Buechler,et al.  Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis , 2017, European journal of clinical investigation.

[36]  A. Ford,et al.  Pathophysiology of irritable bowel syndrome. , 2016, The lancet. Gastroenterology & hepatology.

[37]  J. Kaufman,et al.  Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity , 2016, Obesity.

[38]  C. Buechler,et al.  Chemokine-Like Receptor 1 mRNA Weakly Correlates with Non-Alcoholic Steatohepatitis Score in Male but Not Female Individuals , 2016, International journal of molecular sciences.

[39]  J. Damilakis,et al.  Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease , 2016, European journal of gastroenterology & hepatology.

[40]  O. Yazıcı,et al.  Inflammation and chemerin in colorectal cancer , 2016, Tumor Biology.

[41]  J. Kumar,et al.  The role of chemerin and ChemR23 in stimulating the invasion of squamous oesophageal cancer cells , 2016, British Journal of Cancer.

[42]  A. Stadnyk,et al.  Local chemerin levels are positively associated with DSS-induced colitis but constitutive loss of CMKLR1 does not protect against development of colitis , 2015, Physiological reports.

[43]  A. Kühl,et al.  Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD , 2015, Inflammatory bowel diseases.

[44]  C. Buechler,et al.  Reduced serum chemerin in patients with more severe liver cirrhosis. , 2015, Experimental and molecular pathology.

[45]  M. Hersberger,et al.  ChemR23, the Receptor for Chemerin and Resolvin E1, Is Expressed and Functional on M1 but Not on M2 Macrophages , 2015, The Journal of Immunology.

[46]  A. Zhu,et al.  Prognostic significance of plasma chemerin levels in patients with gastric cancer , 2014, Peptides.

[47]  Wei Zhu,et al.  Disequilibrium of M1 and M2 Macrophages Correlates with the Development of Experimental Inflammatory Bowel Diseases , 2014, Immunological investigations.

[48]  R. Beynon,et al.  Increased Expression of Chemerin in Squamous Esophageal Cancer Myofibroblasts and Role in Recruitment of Mesenchymal Stromal Cells , 2014, PloS one.

[49]  L. Saha.  Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. , 2014, World journal of gastroenterology.

[50]  M. Kukla,et al.  Serum adipokines in inflammatory bowel disease. , 2014, World journal of gastroenterology.

[51]  A. de Bruin,et al.  Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice , 2014, PloS one.

[52]  Xiaofei Xu,et al.  Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization , 2014, Cellular and Molecular Immunology.

[53]  Jun Yu,et al.  Increased serum chemerin level promotes cellular invasiveness in gastric cancer: A clinical and experimental study , 2014, Peptides.

[54]  M. Bauer,et al.  Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. , 2013, European journal of endocrinology.

[55]  C. Buechler,et al.  Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. , 2013, Experimental and molecular pathology.

[56]  P. Delvenne,et al.  Dendritic cells in Barrett's esophagus carcinogenesis: an inadequate microenvironment for antitumor immunity? , 2013, The American journal of pathology.

[57]  M. Fasshauer,et al.  Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. , 2012, Metabolism: clinical and experimental.

[58]  C. Hellerbrand,et al.  Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver , 2012, Molecular and Cellular Endocrinology.

[59]  F. Eren,et al.  Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease , 2011, Scandinavian journal of gastroenterology.

[60]  G. Rogler,et al.  Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease , 2010, Inflammatory bowel diseases.

[61]  M. Kukla,et al.  Serum chemerin and vaspin in non-alcoholic fatty liver disease , 2010, Scandinavian journal of gastroenterology.

[62]  N. Rosenthal,et al.  A CREB-C/EBPβ cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair , 2009, Proceedings of the National Academy of Sciences.

[63]  P. Arner,et al.  Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle Cells , 2009, Diabetes.

[64]  J. Blangero,et al.  Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. , 2009, The Journal of clinical endocrinology and metabolism.

[65]  R. Ohls,et al.  Epithelial cells in fetal intestine produce chemerin to recruit macrophages. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[66]  H. El‐Serag,et al.  Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. , 2008, Gastrointestinal endoscopy.

[67]  P. Zimmet,et al.  Chemerin is a novel adipokine associated with obesity and metabolic syndrome. , 2007, Endocrinology.

[68]  N. Weiss,et al.  Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[69]  M. Parmentier,et al.  The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. , 2007, Blood.

[70]  M. Colombo,et al.  The natural history of compensated cirrhosis due to hepatitis C virus: A 17‐year cohort study of 214 patients , 2006, Hepatology.

[71]  A. Sher,et al.  Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 , 2005, The Journal of experimental medicine.

[72]  A. Mantovani,et al.  Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin , 2005, The Journal of experimental medicine.

[73]  E. Butcher,et al.  Chemokine-Like Receptor 1 Expression and Chemerin-Directed Chemotaxis Distinguish Plasmacytoid from Myeloid Dendritic Cells in Human Blood1 , 2005, The Journal of Immunology.

[74]  W. Forssmann,et al.  Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23 , 2003, FEBS letters.

[75]  Marc Parmentier,et al.  Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids , 2003, The Journal of experimental medicine.

[76]  H. Jacobe,et al.  Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. , 1997, The Journal of investigative dermatology.

[77]  M. Colombo,et al.  Hepatocellular carcinoma in Italian patients with cirrhosis. , 1991, The New England journal of medicine.

[78]  M. El-Sawalhi,et al.  Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis. , 2018, Canadian journal of physiology and pharmacology.

[79]  Wei Lin,et al.  Reduced expression of chemerin is associated with a poor prognosis and a lowed infiltration of both dendritic cells and natural killer cells in human hepatocellular carcinoma. , 2011, Clinical laboratory.